Effects of Levocetirizine and Hydroxyzine on Cognitive and Psychomotor Functioning During Simulated Diving
NCT01496911 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2013-11-06
Summary
Antihistamines are commonly used and currently levocetirizine is most frequently prescribed in the Netherlands. They are commonly used by divers, to solve ear, nose and throat problems, especially to open tubal passage. However, the effects of these drugs on cognitive performance have not been investigated during diving.The objective of this study is to investigate the effects of levocetirizine, hydroxyzine and placebo on cognitive and psychomotor functioning during controlled simulated diving in a hyperbaric chamber in professional navy divers at 10 mt (2 bar) and 30 mt (4 bar).It is hypothesized that hydroxyzine will produce significant impairment, and that the magnitude of impairment is related to hyperbaric pressure.
Conditions
- Healthy Volunteers
Interventions
- DRUG
-
Levocetirizine
a single oral dose of 5 mg
- DRUG
-
Hydroxyzine
a single oral dose of 50 mg
- DRUG
-
a single oral dose
Sponsors & Collaborators
-
Royal Netherlands Navy
collaborator UNKNOWN -
Utrecht Institute for Pharmaceutical Sciences
lead OTHER
Principal Investigators
-
Joris Verster, PhD · Utrecht University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-04-30
- Primary Completion
- 2012-10-31
- Completion
- 2012-10-31
Countries
- Netherlands
Study Locations
More Related Trials
-
Pharmacokinetics of Didehydro-LSD (DDH-LSD) Compared With LSD
NCT07309471 ·Status: RECRUITING ·Phase: NA
-
Inhaled Loxapine vs Intramuscular (IM) Haloperidol + Lorazepam for Agitation
NCT03110900 ·Status: TERMINATED ·Phase: PHASE4
-
Temporal Dynamics and Pharmacokinetics of Intranasally Administered Oxytocin
NCT03011970 ·Status: COMPLETED ·Phase: PHASE1
-
The Role of Stress Neuromodulators in Decision Making Under Risk and Selective Attention to Threat
NCT04359147 ·Status: COMPLETED ·Phase: NA
-
Central Nervous System Effects Following Infusion of Diphenhydramine Using Pharmacokinetic and Pharmacodynamic Modeling
NCT05219604 ·Status: TERMINATED ·Phase: PHASE4
-
The Role of Central Serotonergic and Adrenergic Systems in the Effectiveness of DNIC (Diffuse Noxious Inhibitory Control
NCT00660751 ·Status: COMPLETED ·Phase: NA
-
(+)-Alpha-Dihydrotetrabenazine Phase I
NCT02844179 ·Status: COMPLETED ·Phase: PHASE1
-
Use of Ketamine in Severe Pain Syndromes
NCT06537375 ·Status: COMPLETED
-
Pharmacological Interaction Between Clonidine and Methylenedioxymethamphetamine (MDMA)
NCT01136278 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacological Interaction Between Carvedilol and Methylenedioxymethamphetamine (MDMA)
NCT01270672 ·Status: COMPLETED ·Phase: NA
-
TREC-Lebanon: A Trial for Rapid Tranquilisation for Agitated Patients in the Emergency Setting
NCT03639558 ·Status: COMPLETED ·Phase: PHASE4
-
BXCL501 After Stress to Increase Recovery Success
NCT06943404 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy of a Therapeutic Combination of Dronabinol and PEA for Tourette Syndrome
NCT03066193 ·Status: COMPLETED ·Phase: PHASE2
-
Study of 3,4-Methylenedioxymethamphetamine-assisted Psychotherapy in People With Posttraumatic Stress Disorder
NCT00353938 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Oxytocin and Lorazepam on Fear-related Intra-amygdalar Activity
NCT03829839 ·Status: COMPLETED ·Phase: PHASE1
-
Influence of Oxytocin on Resting State Neurophysiological Measures
NCT03255148 ·Status: COMPLETED ·Phase: PHASE1
-
Abuse Potential and Human Pharmacology of Methylone
NCT05488171 ·Status: UNKNOWN ·Phase: PHASE1
-
Effectiveness of tDCS on Reducing Craving in Patients Practicing Chemsex: a Single-center, Double-blind, Randomized Controlled Pilot Trial
NCT05945199 ·Status: RECRUITING ·Phase: NA
-
Propranolol Versus Propranolol and Clonidine in Sympathetic Hyperactivity After Moderate Traumatic Brain Injury
NCT04833218 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Effect of Sublingual Formulation of Dexmedetomidine Hydrochloride (HCl) (BXCL501) - Outpatient Study
NCT06335407 ·Status: RECRUITING ·Phase: PHASE1
-
The Effects of MDMA on Prefrontal and Amygdala Activation in PTSD.
NCT03752918 ·Status: WITHDRAWN ·Phase: PHASE1
-
Effects of Transdermal Scopolamine on Occupational Performance
NCT00374478 ·Status: COMPLETED ·Phase: PHASE2
-
Explorative Efficacy Profile of Neurexan® in an Experimental Acute Stress Setting in Healthy Subjects
NCT01703819 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Influence of Oxytocin on Socio-communicative Sensitivity
NCT03096249 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Lack of Acute Tolerance Development to Effects of Nitrous Oxide - 4
NCT00000252 ·Status: COMPLETED ·Phase: PHASE2